TMS Media Coverage
NATIONAL MEDIA
Transcranial Magnetic Stimulation (TMS) has been featured in several prominent news publications highlighting its success in treating depression. Among these publications are: National Geographic, Scientific American, Psychiatric Times, Harvard Health, Men’s Health, and Forbes. See below for more news stories discussing the latest applications of TMS Therapy.
NeuroStar TMS and the Future of MDD Treatment for Adolescents
NeuroStar transcranial magnetic stimulation (TMS) was cleared by the US Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD) in adolescents in March 2024.1
learn more
04/18/2024
What Is Transcranial Magnetic Stimulation (TMS)?
TMS therapy, or transcranial magnetic stimulation, is a noninvasive (non-surgical) form of therapy that uses a series of short, magnetic pulses to stimulate nerve cells in your brain.
learn more
03/05/2024
Transcranial Magnetic Stimulation (TMS) for Depression
TMS is approved by the Food and Drug Administration (FDA) or treatment of major depressive disorder (MDD, or depression), obsessive-compulsive disorder (OCD), and smoking cessation.
learn more
02/18/2024
What is transcranial magnetic stimulation?
It’s a disorder that impacts millions. And for some living with depression, it’s tough to treat.
A depression treatment you might not be aware of is yielding fantastic results.
learn more
01/28/2024
Transcranial Magnetic Stimulation depression treatment gives an Ohioan his life back
Eric Clark knows first hand. He struggled with depression for most of his life. “I’ve been dealing with mental health illness, like depression, since I was 14. About five years ago,
learn more
12/15/2023
Novel TMS protocol shows promise for treating hard-to-treat depression
By making slight modifications to an already approved brain stimulation technique called transcranial magnetic stimulation (TMS),
learn more
11/29/2023
For more news articles featuring TMS, please see this Press Coverage page.